Commentaries
Autoimmune pancreatitis
Optimising corticosteroid treatment for autoimmune pancreatitis
Division of Gastroenterology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
Correspondence to:
Suresh Chari, 200 First Street SW, Rochester, MN 55905, USA; chari.suresh@mayo.edu
Unanswered questions
| The first 150 words of the full text of this article appear below. |
Autoimmune pancreatitis (AIP) is part of a systemic fibro-inflammatory disease that can involve multiple organs which characteristically have a lymphoplasmacytic infiltrate rich in IgG4-positive cells. IgG4-related systemic disease (ISD) has been proposed by Kamisawa et al as the umbrella term to describe this multi-organ disease.1 Although the fibrosis in ISD can often lead to damage and even destruction of the involved organ, the inflammatory process typically responds to steroid treatment. However, the resolution of the inflammatory process in ISD may occur spontaneously without steroid treatment, especially in AIP.2 3 The effect of steroid treatment on the natural history of AIP is not known as it is only recently that large series of AIP are being reported.
In this issue of Gut (page 1719), Hirano et al4 report the results of a retrospective review of 42 AIP patients of whom 19 were treated with steroids. The authors goal
This article has been cited by other articles:
-
Park, D H, Kim, M-H, Chari, S T
(2009). Recent advances in autoimmune pancreatitis. Gut
58: 1680-1689
[Abstract] [Full Text] -
Pannala, R., Chari, S. T
(2009). Corticosteroid treatment for autoimmune pancreatitis. Gut
58: 1438-1439
[Full Text] -
Kamisawa, T, Shimosegawa, T, Okazaki, K, Nishino, T, Watanabe, H, Kanno, A, Okumura, F, Nishikawa, T, Kobayashi, K, Ichiya, T, Takatori, H, Yamakita, K, Kubota, K, Hamano, H, Okamura, K, Hirano, K, Ito, T, Ko, S B H, Omata, M
(2009). Standard steroid treatment for autoimmune pancreatitis. Gut
58: 1504-1507
[Abstract] [Full Text] -
LAW, R., BRONNER, M., VOGT, D., STEVENS, T.
(2009). Autoimmune pancreatitis: A mimic of pancreatic cancer. Cleveland Clinic Journal of Medicine
76: 607-615
[Abstract] [Full Text] -
Hirschfield, G. M., Al-Harthi, N., Heathcote, E. J.
(2009). Review: Current status of therapy in autoimmune liver disease. Therapeutic Advances in Gastroenterology
2: 11-28
[Abstract]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
